Liu JO - Search Results

1

Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies.

Lu L, Jiang J, Zhan M, Zhang H, Wang QT, Sun SN, Guo XK, Yin H, Wei Y, Li SY, Liu JO, Li Y, He YW. Lu L, et al. Among authors: liu jo. Hepatology. 2021 Feb;73(2):821-832. doi: 10.1002/hep.31502. Hepatology. 2021. PMID: 32767586 Review. No abstract available.

2

Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?

Lu L, Jiang J, Zhan M, Zhang H, Wang QT, Sun SN, Guo XK, Yin H, Wei Y, Liu JO, Li SY, Li Y, He YW. Lu L, et al. Among authors: liu jo. Hepatology. 2021 Jan;73(1):414-421. doi: 10.1002/hep.31279. Hepatology. 2021. PMID: 32299136 Review. No abstract available.

3

A method for overcoming plasma protein inhibition of tyrosine kinase inhibitors.

Young DJ, Nguyen B, Li L, Higashimoto T, Levis MJ, Liu JO, Small D. Young DJ, et al. Among authors: liu jo. Blood Cancer Discov. 2021 Sep;2(5):532-547. doi: 10.1158/2643-3230.BCD-20-0119. Epub 2021 Jul 2. Blood Cancer Discov. 2021. PMID: 34589716 Free PMC article.

4

Targeting cancer with molecular glues.

Liu JO. Liu JO. Science. 2023 Aug 18;381(6659):729-730. doi: 10.1126/science.adj1001. Epub 2023 Aug 17. Science. 2023. PMID: 37590349

5

Insights into the structure-activity relationship of the anticancer compound ZJ-101: A role played by the amide moiety.

Qiu H, Qian S, Head SA, Sanchez PR, Liu JO, Jin Z. Qiu H, et al. Among authors: liu jo. Bioorg Med Chem Lett. 2024 Jun 1;105:129741. doi: 10.1016/j.bmcl.2024.129741. Epub 2024 Apr 9. Bioorg Med Chem Lett. 2024. PMID: 38599296

6

Dimethyl Fumarate Protects against Lipopolysaccharide- (LPS-) Induced Sepsis through Inhibition of NF-κB Pathway in Mice.

Fang H, Wang X, Damarla M, Sun R, He Q, Li R, Luo P, Liu JO, Xia Z. Fang H, et al. Among authors: liu jo. Mediators Inflamm. 2023 Oct 5;2023:5133505. doi: 10.1155/2023/5133505. eCollection 2023. Mediators Inflamm. 2023. PMID: 37840694 Free PMC article.

7

Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C.

Zhu P, Li SY, Ding J, Fei Z, Sun SN, Zheng ZH, Wei D, Jiang J, Miao JL, Li SZ, Luo X, Zhang K, Wang B, Zhang K, Pu S, Wang QT, Zhang XY, Wen GL, Liu JO, August JT, Bian H, Chen ZN, He YW. Zhu P, et al. Among authors: liu jo. J Pharm Anal. 2023 Jun;13(6):616-624. doi: 10.1016/j.jpha.2023.04.012. Epub 2023 Apr 21. J Pharm Anal. 2023. PMID: 37440907 Free PMC article.

8

An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.

Reyes Gaido OE, Pavlaki N, Granger JM, Mesubi OO, Liu B, Lin BL, Long A, Walker D, Mayourian J, Schole KL, Terrillion CE, Nkashama LJ, Hulsurkar MM, Dorn LE, Ferrero KM, Huganir RL, Müller FU, Wehrens XHT, Liu JO, Luczak ED, Bezzerides VJ, Anderson ME. Reyes Gaido OE, et al. Among authors: liu jo. Sci Transl Med. 2023 Jun 21;15(701):eabq7839. doi: 10.1126/scitranslmed.abq7839. Epub 2023 Jun 21. Sci Transl Med. 2023. PMID: 37343080 Free PMC article.

9

Synthesis and biological evaluation of biotinylated ZJ-101.

Qian S, Head SA, Sanchez PR, Liu JO, Jin Z. Qian S, et al. Among authors: liu jo. Bioorg Med Chem Lett. 2023 Jul 15;91:129372. doi: 10.1016/j.bmcl.2023.129372. Epub 2023 Jun 8. Bioorg Med Chem Lett. 2023. PMID: 37301523

10

Modulation of the Endomembrane System by the Anticancer Natural Product Superstolide/ZJ-101.

Sanchez PR, Head SA, Qian S, Qiu H, Roy A, Jin Z, Zheng W, Liu JO. Sanchez PR, et al. Among authors: liu jo. Int J Mol Sci. 2023 May 31;24(11):9575. doi: 10.3390/ijms24119575. Int J Mol Sci. 2023. PMID: 37298526 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page